AlzFormer:基于视频的时空注意力模型用于早期诊断阿尔茨海默病
Taymaz Akan1, Sara Akan2, Sait Alp3
1Department of Medicine, LSU Health Shreveport, Shreveport, LA, USA; Department of Software Engineering, Faculty of Engineering, Istanbul Topkapı University, Istanbul, Turkey.
Neuroscience
|September 5, 2025
概括
AlzFormer是一种新的深度学习模型,使用MRI扫描精确分类阿尔茨海默病 (AD),轻度认知障碍 (MCI) 和认知正常 (CN). 这种人工智能方法对早期可靠的脑疾病诊断有很大希望.
科学领域:
- 神经成像和人工智能
- 计算神经科学
- 医疗诊断
背景情况:
- 早期和准确的阿尔茨海默病诊断对于干预至关重要,但由于神经退行缓慢,仍然具有挑战性.
- 深度学习技术在使用医疗成像进行脑疾病的计算机辅助诊断方面具有显著的潜力.
- 结构磁共振成像 (sMRI) 为分析与神经退行性疾病相关的大脑变化提供了有价值的数据.
研究的目的:
- 介绍AlzFormer,一种使用时空注意力机制的新型深度学习框架,用于AD,轻度认知障碍 (MCI) 和认知正常 (CN) 个体的多类分类.
- 通过将它们视为顺序输入来利用基于变压器的架构来模拟T1加权的MRI体积中的切片间连续性.
- 通过sMRI评估AlzFormer的诊断性能和可解释性.
主要方法:
- 开发AlzFormer,一个使用时空自我注意机制的深度学习模型.
- 处理T1权重的MRI体积作为连续输入,与视频相似的切片,以捕捉切片间的关系.
- 对阿尔茨海默病神经成像计划 (ADNI) 数据集的模型进行微调和评估,包括头骨剥离和MNI空间正常化等预处理步骤.
主要成果:
- 在测试组中,AlzFormer获得了94%的高整体精度.
- 获得了优异的平衡类F1分数:AD为0. 94,MCI为0. 99和CN为0. 98.
- 获得了0.98的宏观平均曲线下面面积 (AUC) 和重点突出AD相关的大脑区域的注意力图分析.
结论:
- AlzFormer使用结构MRI证明了阿尔茨海默病,MCI和CN的强大和可解释的分类.
- 基于变压器的架构有效地模拟MRI数据中的空间和时间信息,以提高诊断准确性.
- 这种方法有很大的潜力通过先进的神经影像分析来提前和可靠地诊断大脑疾病.
更多相关视频
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
8.0K
08:43Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
8.0K
相关概念视频
01:26Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
01:22Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
01:30Dementia
165
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
165